"increased competition for patients with liver-directed therapies, a new drug approval in salvage metastatic colorectal cancer and restrictions in reimbursement."
How are they going to overcome this increased competition and new drug approval ???
"increased competition for patients with liver-directed...
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $65.79M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.5¢ | $72.22K | 465.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1020612 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 2490576 | 25 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |